Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CNSL, ED, PROT.OB, & CGX: Consolidated Graphics Provides Personalized Promotional Items through New Forte Select Line


signup3m

Consolidated Communications Holdings, Inc. (Nasdaq:CNSL)

Consolidated Communications Holdings, Inc. is an established rural local exchange company providing communication services to residential and business customers in Illinois, Texas and Pennsylvania. As of June 30, 2010, the Company had 242,282 ILEC access lines, 73,686 Competitive Local Exchange Carrier (CLEC) access line equivalents, 103,428 DSL subscribers and 26,074 IPTV subscribers. The Company offers a wide range of telecommunications services, including local and long distance service, custom calling features, private line services, high-speed Internet access, digital TV, carrier access services and directory publishing.

On August 2, 2010, the board of directors of Consolidated Communications Holdings, Inc. declared a quarterly dividend of $0.38738 per share on the company's common stock. The dividend is payable on November 1, 2010 to stockholders of record at the close of business on October 15, 2010.

_________________________________________

Consolidated Edison, Inc. (NYSE:ED)

Consolidated Edison, Inc. provides a wide range of energy-related products and services to its customers through the following subsidiaries: Consolidated Edison Company of New York, Inc., a regulated utility providing electric, gas, and steam service in New York City and Westchester County, New York; Orange and Rockland Utilities, Inc., a regulated utility serving customers in a 1,350 square mile area in southeastern New York and adjacent sections of northern New Jersey and northeastern Pennsylvania; Consolidated Edison Solutions, Inc., a retail energy supply and services company; Consolidated Edison Energy, Inc., a wholesale energy supply company; and Consolidated Edison Development, Inc., a company that participates in infrastructure projects.

Consolidated Edison, Inc. announced today it has agreed to issue 6,300,000 of its common shares. These common shares are being offered by Morgan Stanley & Co. Incorporated under Con Edison's effective shelf registration statement filed with the Securities and Exchange Commission. The common shares are expected to be issued on October 1, 2010, subject to customary closing conditions.

Con Edison expects to invest the net proceeds from the sale of the common shares in its regulated utility subsidiary, Consolidated Edison Company of New York, Inc., for funding of its construction expenditures and for its other general corporate purposes.

_________________________________________

Proteonomix Inc (OTC BB: PROT.OB)

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging skin care products. StromaCel, Inc.'s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix's operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (”PRTMI“) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies.

PROTEONOMIX, INC., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company. For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

 

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

PROT, a biotechnology company, engages in the development of stem cell therapies primarily for the treatment of diabetes and cardiac therapy, as well as offers cosmeceutical products. The stem cell therapy involves the introduction of healthy new stem cells to repair and replace damaged or lost cells. PROT offers product for the treatment of anti-aging and damaged skin.

Provision for the Distribution of Proteoderm, Proteonomix, Inc.'s new Anti-aging line of skin care products (www.proteoderm.com)

Additionally, the agreement calls for XGen, the joint venture, to market and distribute Proteoderm, including the Matrix NC-138 anti-aging products.

You should watch this company, as their product is the type that is in demand at lease in the western culture. Make a decision by yourself!

More about PROT at: www.proteonomix.com

_________________________________________

Consolidated Graphics, Inc. (NYSE:CGX)

Consolidated Graphics, Inc., headquartered in Houston, Texas, is one of North America's leading general commercial printing companies. With 70 printing businesses strategically located across 27 states, Toronto, and Prague, and a presence in Asia, CGX offers an unmatched geographic footprint, unsurpassed capabilities, and unparalleled levels of convenience, efficiency and service. With locations in or near virtually every major U.S. market, CGX provides service and responsiveness of a local printer enhanced by the economic, geographic and technological advantages of a large national organization.

Orange County Printing (OCP), a Consolidated Graphics, Inc. company, officially announced the launch of Forte Select, a line of personalized promotional gift and apparel items. Orange County Printing also manages the Forte Promotional Products line

Unlike traditional promotional product providers, Orange County Printing's Forte Select enables users to create one-off pieces such as mugs, mouse pads, and t-shirts that are personalized with individuals' names, images, or other custom content. The launch of Forte Select provides a value-added service that builds from the reputation of Forte Promotional Products, both of which are available and sold through OCP and all 70 Consolidated Graphics companies. Forte products are also available directly at www.our-forte.com.

 

 

 

 

 

*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************

 

business Card 3




 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (OTCPK:PROT)

*******************************************



Disclosure: No positions